Maha Katabi - 14 May 2025 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Director
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol: VERA
Transactions as of: 14 May 2025
Net transactions value: $0
Form type: 4
Filing time: 16 May 2025, 16:13:51 UTC
Previous filing: 07 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Katabi Maha	Director	C/O SOFINNOVA INVESTMENTS, INC., 3000 SAND HILL ROAD, BLDG. 4, SUITE 250, MENLO PARK	/s/ Joseph R. Young, Attorney-in-Fact	16 May 2025	0001720685

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award	$0	+14,000		$0.000000	14,000	14 May 2025	Class A Common Stock	14,000	$21.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Content

The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.